Drug Details
Therapeutic Class:
PDE5 inhibitors
Forms:
Tablet, liquid suspension
Administration:
By mouth
Therapeutic Uses:
Pulmonary arterial hypertension (PAH)
Controlled Status:
Not a controlled substance
Adcirca Drug Class
Adcirca (ad-sir-kah) is a phosphodiesterase-5 (PDE5) inhibitor.
Adcirca Age Range
Adcirca is approved for use in adults. The safety and efficacy of this medication have not been established in pediatric patients.
SOCIAL